BiotechTube
Home/Nxera Pharma/Chris Cargill
CC

Chris Cargill

President & CEO

Nxera Pharma

Therapeutic Areas

NeuroscienceImmuno-oncology

Nxera Pharma Pipeline

DrugIndicationPhase
HTL0018318Alzheimer's Disease Psychosis, SchizophreniaPhase 2
HTL0014242SchizophreniaPhase 1
HTL0039732Oncology (Immuno-oncology)Phase 1
HTL0046509Ulcerative ColitisPreclinical
HTL0016878Chronic Kidney Disease, Metabolic DisordersPreclinical

Leadership Team at Nxera Pharma

ST
Shinichi Tamura
Chairman & Representative Director
MC
Miles Congreve, FRS
Chief Scientific Officer & Sosei Heptares COO
MW
Malcolm Weir, Ph.D.
Executive VP, R&D and Chief R&D Officer
RG
Robert Gould, Ph.D.
Non-Executive Director
View full Nxera Pharma profile